Skip to main content

LDK 150MG NVR Pill - blue & white capsule/oblong

Generic Name: ceritinib

Pill with imprint LDK 150MG NVR is Blue & White, Capsule/Oblong and has been identified as Zykadia 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Zykadia is used in the treatment of Non Small Cell Lung Cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Zykadia 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LDK 150MG NVR

Zykadia 150 mg LDK 150MG NVR
Zykadia 150 mg LDK 150MG NVR

Zykadia

Generic Name
ceritinib
Imprint
LDK 150MG NVR
Strength
150 mg
Color
Blue & White
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Multikinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)
00078-0640 (Discontinued)
Inactive Ingredients
silicon dioxide, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato, gelatin, titanium dioxide, FD&C Blue No. 2

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.